Literature DB >> 25409968

Roux-en-Y gastric bypass: limb length and weight loss.

Antonio Carlos Valezi1, Antonio César Marson1, Rodrigo Alves Merguizo1, Fernando Leão Costa1.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass is a surgical technique widely used in the treatment of obesity. It is unclear, however, if the length of the biliopancreatic and alimentary limb interferes with the magnitude of weight loss. AIM: To evaluate if the length of these limbs is related to the percentage of weight loss one year after surgery.
METHOD: One hundred and twenty obese people underwent surgery between 2009 and 2011. Patients were inserted into four groups: A) biliopancreatic limb with 50 cm length and alimentary limb with 100 cm length; B) biliopancreatic limb with 50 cm length and alimentary limb with 150 cm length; C) biliopancreatic limb with 100 cm length and alimentary limb with 100 cm length; D) biliopancreatic limb with 100 cm length and alimentary limb with 150 cm length. Age, gender, body mass index and the percentage of total weight loss were analyzed. Data were collected preoperatively and one year after surgery. The groups were compared and weight loss compared between groups.
RESULTS: The follow-up occurred in 78.3% of the sample. The composition of the groups was similar, with no statistical significance. The average age was 43 years in groups A, C and D and 42 years in group B. The female gender predominated in all groups (about 60% of the sample). The mean body mass index was 46 kg/m2 for groups A, C and D and 42 kg/m2 in group B. The percentage of weight loss was 33% for group A and 34% for groups B, C and D. There was no significant difference among groups.
CONCLUSION: Different lengths of the biliopancreatic and alimentary limbs did not affect the percentage of total weight loss.

Entities:  

Mesh:

Year:  2014        PMID: 25409968      PMCID: PMC4743521          DOI: 10.1590/s0102-6720201400s100014

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


INTRODUCTION

Bariatric surgery is the best treatment for obese patients, being effective method in reducing and maintaining weight in the long time[6,17]. Surgical treatment for obesity causes weight loss and improvement in comorbidities[2,18]. Roux-en-Y gastric bypass (RYGBP) is one of the most performed surgeries for this purpose; however, it is unclear whether technical factors, as the limb length, has relevance in outcomes[8,19]. The length of alimentary and biliopancreatic limbs and their relationship with weight loss determined by RYGBP is controversial, with doubts about the ideal length of these limbs[16]. The aim of this study is to investigate the relationship between the length of these limbs and the weight loss, comparing different length limbs and the total weight loss one year after surgery.

METHOD

The study was approved by the Ethics and Research Committee of the University Hospital of the State University of Londrina under number 026/2008. The Instrument of Consent was presented and signed by all subjects of study. The authors declare no conflict of interest present in this research. One hundred and twenty obese people underwent Roux-en-Y gastric bypass at the University Hospital of the State University of Londrina, PR, Brazil by the same team, from January 2009 to December 2011. This research was designed according to a randomized and prospective study. The criteria for inclusion and exclusion of patients in the surgical treatment of obesity program, obeyed the principles of the Brazilian Society for Bariatric and Metabolic Surgery. For the research, four groups were constituted by draw, immediately before the surgical procedure: group A: biliopancreatic limb length of 50 cm and alimentary limb length of 100 cm; group B: biliopancreatic limb length of 50 cm and alimentary limb length of 150 cm; group C: biliopancreatic limb length of 100 cm and alimentary limb length of 100 cm; group D: biliopancreatic limb length of 100 cm and alimentary limb length of 150 cm. The variables were age, gender, body mass index (BMI) and percentage of total weight loss. The following sample was carried out for one year. The groups were compared as to their constitution. The percentage of weight loss was measured at one year postoperatively and compared between groups during this period. The collected data were stored in Excel and analyzed later through software Statistical Package for the Social Sciences 18.0 (SPSS). Were calculated the mean and standard deviation for quantitative variables and comparison between groups was made by analysis of variance (ANOVA). Categorical variables were compared using the Levene test. For all variables, statistical significance was considered if p ≤ 0:05.

RESULTS

The one year follow up was 78,3% of the whole sample or 94 patients (24 in group A; 25 in group B; 23 in group C and 22 in group D). Composition of each group was homogeneous according to age, gender and BMI. There was no statistic significance between them (Table 1).
TABLE 1

Demographic characteristics of the groups

 ABCDp
Age (years)43,97 SD= 10,9342,87 SD=9,5343,13 SD=9,5043,73 SD=10,700,64
Female (%)19 (63,3)18 (60,00)19 (63,33)17 (56,66) 
BMI (kg/m2)[*]46,9 SD= 5,69 47,64 SD= 5,7246,81 SD=5,5046,10 SD= 5,390,92

BMI=body mass index; SD=standard deviation

Demographic characteristics of the groups BMI=body mass index; SD=standard deviation Group A showed total weight loss of 33.27% one year after surgery; group B, 34.07%; and group C and D, 34% for the same period. When comparing the total weight loss between groups at one year postoperatively, there was no statistical significance (Table 2).
TABLE 2

Percentage of total weight loss for the groups

A B C D p
% weight loss33,2734,07 34,00 34,00 0,66
Standard deviationDP= 2,20DP= 2,97DP= 2,16DP= 2,61 
Percentage of total weight loss for the groups

DISCUSSION

RYGBP was used for this research because it is the most frequent surgery performed in the department for obese people. It's known that RYGBP presents its results, not only due to anatomical factors imposed by the technique - such as decreased food intake by making small gastric pouch or decreased absorption due to the Roux-en-Y reconstruction[13]. Its effects results from neuroendocrine changes that occur because of anatomical changes caused by technical modifications[1,9,15]. It is not clear whether the length of the limbs affects the result of weight loss[11]. It seems rational that the more distal the Roux-en-Y the greater the weight loss. It must make the distinction between long Roux-en-Y and distal Roux-en-Y. The latter is characterized by anastomosis in the distal ileum, with a common limb about 75 cm; in this case there is more significant weight loss, but with a considerable increase in the rate of complications[10]. Longer Roux-en-Y limb presents variation in the length of alimentary and biliopancreatic limbs, but only with extensive common limb[4]. This study evaluated the percentage loss of total weight, not of the weight excess. This fact made it easier to collect data and, as far as the entire series was evaluated in the same manner, the adoption of this index did not add bias to the study. In 1992, Brolin et al.[3] showed a prospective randomized study comparing weight loss in patients with short Roux-en-Y (biliopancreatic limb with 15 cm and alimentary with 75 cm) and long Roux-en-Y (biliopancreatic limb with 30 cm and alimentary limb with 150 cm) and concluded that those with more distal anastomosis showed more significant weight loss at two years follow up, with no significant nutritional changes. Since then, it was thought to lengthen the Y for the super obese or in cases with failure in weight loss and gastric pouch of normal size. Sarhan et al.[14] compared standard and long Roux-en-Y (250 cm biliopancreatic limb) in super-obese and found no difference; they concluded that the length of the limb does not impact weight loss. Choban and Flancbaum[5] compared patients with different lengths of alimentary limb (75 cm, 150 cm and 250 cm) and stratified the sample according to BMI. Their results showed significantly more weight loss in the group with 250 cm limb and super obese at 18 months postoperatively, this difference disappeared at 24 months follow-up. Feng et al.[7] found no statistically significant difference in one year follow-up comparing a group with biliopancreatic limb of 50 cm and alimentary limb of 100 cm, with another that had biliopancreatic limb of 100 cm and alimentary of 150 cm long. In our country, Ramos[12] in a retrospective study examined diabetic patients with metabolic syndrome and divided them into three groups: biliopancreatic limb with 50 cm and alimentary limb with100 cm; biliopancreatic limb with 50 cm and alimentary limb with 150 cm and biliopancreatic limb with 100 cm and alimentary with 150 cm long. In a 12 months follow-up, he concluded that the different sizes of limbs had no effect on weight loss and improving metabolic syndrome. This study, similar to Ramos[12], showed similar percentage of weight loss in all groups (around 34%) without statistical significance. These authors know that this study does not present unpublished results. The findings corroborate survey data that had been shown previously. The series is not small and the authors intend to continue it to evaluate the impact of different measures of limb in diabetic population.

CONCLUSION

Different lengths of the biliopancreatic and alimentary limbs did not affect the percentage of total weight loss.
  18 in total

1.  Relationship of bypassed limb length and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass.

Authors:  Yu-Hsi Kao; Chi-Hsien Lo; Chih-Kun Huang
Journal:  Surg Obes Relat Dis       Date:  2011-10-30       Impact factor: 4.734

2.  Is weight loss better sustained with long-limb gastric bypass in the super-obese?

Authors:  Mohammad Sarhan; Jenny J Choi; Monqidh Al Sawwaf; Ghulam Murtaza; Jorge L Zelada Getty; Leaque Ahmed
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

Review 3.  Mechanisms underlying weight loss after bariatric surgery.

Authors:  Alexander D Miras; Carel W le Roux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

Review 4.  Bariatric surgeries: beyond restriction and malabsorption.

Authors:  D Sandoval
Journal:  Int J Obes (Lond)       Date:  2011-09       Impact factor: 5.095

Review 5.  Cardiovascular benefits of bariatric surgery in morbidly obese patients.

Authors:  V G Athyros; K Tziomalos; A Karagiannis; D P Mikhailidis
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

6.  Malabsorptive gastric bypass in patients with superobesity.

Authors:  Robert E Brolin; Lisa B LaMarca; Hallis A Kenler; Ronald P Cody
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

7.  Long-term results of malabsorptive distal Roux-en-Y gastric bypass in superobese patients.

Authors:  John M Kellum; Silas M Chikunguwo; James W Maher; Luke G Wolfe; Harvey J Sugerman
Journal:  Surg Obes Relat Dis       Date:  2010-10-11       Impact factor: 4.734

8.  Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model.

Authors:  Gil R Faria; John R Preto; José Costa-Maia
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

9.  Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.

Authors:  Christian-Heinz Anderwald; Andrea Tura; Miriam Promintzer-Schifferl; Gerhard Prager; Marietta Stadler; Bernhard Ludvik; Harald Esterbauer; Martin Georg Bischof; Anton Luger; Giovanni Pacini; Michael Krebs
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

10.  Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.

Authors:  Meera Shah; Jennie H Law; Francesco Micheletto; Matheni Sathananthan; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Michael Camilleri; Alan R Zinsmeister; Adrian Vella
Journal:  Diabetes       Date:  2013-10-02       Impact factor: 9.461

View more
  11 in total

1.  CORRELATION BETWEEN PRE AND POSTOPERATIVE LEVELS OF GLP-1/GLP-2 AND WEIGHT LOSS AFTER ROUX-EN-Y GASTRIC BYPASS: A PROSPECTIVE STUDY.

Authors:  Everton Cazzo; Martinho Antonio Gestic; Murillo Pimentel Utrini; José Carlos Pareja; Elinton Adami Chaim; Bruno Geloneze; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

2.  The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults.

Authors:  Mahdieh Golzarand; Karamollah Toolabi; Roya Farid
Journal:  Surg Endosc       Date:  2017-04-04       Impact factor: 4.584

Review 3.  GLP-2: A POORLY UNDERSTOOD MEDIATOR ENROLLED IN VARIOUS BARIATRIC/METABOLIC SURGERY-RELATED PATHOPHYSIOLOGIC MECHANISMS.

Authors:  Everton Cazzo; Martinho Antonio Gestic; Murillo Pimentel Utrini; Felipe David Mendonça Chaim; Bruno Geloneze; José Carlos Pareja; Elinton Adami Chaim; Daniéla Oliveira Magro
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

4.  A short or a long Roux limb in gastric bypass surgery: does it matter?

Authors:  Kemal Dogan; Jens Homan; Edo O Aarts; Cees J H M van Laarhoven; Ignace M C Janssen; Frits J Berends
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

5.  Hepatic artery pseudoaneurysm following percutaneous transhepatic cholangiogram: an extremely rare complication.

Authors:  Pratyusha Tirumanisetty; Jose William Sotelo; Aditya Rander; Taussif Syed
Journal:  BMJ Case Rep       Date:  2019-07-12

Review 6.  Small Bowel Limb Lengths and Roux-en-Y Gastric Bypass: a Systematic Review.

Authors:  Kamal K Mahawar; Parveen Kumar; Chetan Parmar; Yitka Graham; William R J Carr; Neil Jennings; Norbert Schroeder; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

7.  Biliopancreatic Limb Length of Small Intestinal Bypass in Non-obese Goto-Kakizaki (GK) Rats Correlates with Gastrointestinal Hormones, Adipokines, and Improvement in Type 2 Diabetes.

Authors:  Qiwei Zhang; Zhi Hong; Jieyao Zhu; Chao Zeng; Zhen Tang; Weiqiang Wang; He Huang
Journal:  Obes Surg       Date:  2021-07-26       Impact factor: 4.129

8.  Whether a Short or Long Alimentary Limb Influences Weight Loss in Gastric Bypass: a Systematic Review and Meta-Analysis.

Authors:  Jiadi Gan; Yingjin Wang; Xiaodong Zhou
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

9.  Short versus long biliopancreatic limb in Roux-en-Y gastric bypass surgery for treatment of type 2 diabetes mellitus.

Authors:  Zhigang Ke; Fan Li; Yu Gao; Xunmei Zhou; Fang Sun; Li Wang; Jing Chen; Xin Tan; Zhiming Zhu; Weidong Tong
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-10-14       Impact factor: 1.195

10.  The role of alimentary and biliopancreatic limb length in outcomes of Roux-en-Y gastric bypass.

Authors:  Sattar Darabi; Abdoreza Pazouki; Fatemeh Sadat Hosseini-Baharanchi; Ali Kabir; Mohammad Kermansaravi
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-16       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.